Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc.
Defendant / Appellee: MYLAN PHARMACEUTICALS INC.
Plaintiff / Appellant: TAKEDA PHARMACEUTICALS U.S.A., INC.
Case Number: 20-1417
Filed: January 31, 2020
Court: U.S. Court of Appeals, Federal Circuit
Nature of Suit: Other
Docket Report

This docket was last retrieved on February 19, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
February 19, 2020 Filing 15 Note to file: The following cases are associated:20-1407 (Lead) with 20-1417 (Member Case). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [672567] [20-1407, 20-1417] [TAM] [Entered: 02/19/2020 04:33 PM]
February 19, 2020 Opinion or Order Filing 14 ORDER consolidating the appeals. The revised official caption is reflected above. One set of briefs should be filed for the two appeals. Takeda's opening brief remains due no later than February 19, 2020. Service as of this date by the Clerk of Court. [672520] [20-1407, 20-1417] [LMS] [Entered: 02/19/2020 03:33 PM]
February 13, 2020 Filing 13 Entry of appearance for Shyamkrishna Palaiyanur as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671183] [20-1417] [Shyamkrishna Palaiyanur] [Entered: 02/13/2020 04:53 PM]
February 13, 2020 Filing 12 Entry of appearance for Sheryl Shapiro Bassin as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671182] [20-1417] [Sheryl Shapiro Bassin] [Entered: 02/13/2020 04:51 PM]
February 13, 2020 Filing 11 Entry of appearance for Jessica L. Margolis as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671181] [20-1417] [Jessica Margolis] [Entered: 02/13/2020 04:49 PM]
February 13, 2020 Filing 10 Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671179] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:47 PM]
February 13, 2020 Filing 9 Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671178] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:46 PM]
February 13, 2020 Filing 8 Entry of appearance for Michael S. Sommer as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671177] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:45 PM]
February 12, 2020 Filing 7 Docketing Statement for the Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670844] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:43 PM]
February 12, 2020 Filing 6 Certificate of Interest for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670842] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:42 PM]
February 12, 2020 Filing 5 Entry of appearance for Camille Y. Turner as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670840] [20-1417] [Jonathan Herstoff] [Entered: 02/12/2020 03:40 PM]
February 12, 2020 Filing 4 Entry of appearance for Jonathan A. Herstoff as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670838] [20-1417] [Jonathan Herstoff] [Entered: 02/12/2020 03:38 PM]
February 12, 2020 Filing 3 Entry of appearance for Porter F. Fleming as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670836] [20-1417] [Porter Fleming] [Entered: 02/12/2020 03:37 PM]
February 12, 2020 Filing 2 Entry of appearance for Edgar H. Haug as principal counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670834] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:34 PM]
January 31, 2020 Filing 1 Appeal docketed. Received: 01/28/2020. [667547] Entry of Appearance due 02/14/2020. Certificate of Interest is due on 02/14/2020. Docketing Statement due 02/14/2020. Appellant's brief is due 03/31/2020. [TAM] [Entered: 01/31/2020 09:43 AM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: MYLAN PHARMACEUTICALS INC.
Represented By: David S. Steuer
Represented By: Shyamkrishna Palaiyanur
Represented By: Jessica Margolis
Represented By: Sheryl Shapiro Bassin
Represented By: Michael S. Sommer
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellant: TAKEDA PHARMACEUTICALS U.S.A., INC.
Represented By: Francis DiGiovanni
Represented By: Porter F. Fleming
Represented By: Jonathan Herstoff
Represented By: Edgar Haug
Represented By: Camille Yvette Turner
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?